11/19/2007

The CDC will assess hospital methicillin-resistant Staphylococcus aureus prevention programs with its Active Bacterial Core Surveillance system. The agency will conduct a baseline survey and two follow-up surveys over three years to ensure facilities are using its guidelines to reduce the transmission of drug-resistant infections.

Related Summaries